Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
Geburtshilfe Und Frauenheilkunde|January 5, 2024
RANK and RANKL Expression in Tumors of Patients with Early Breast CancerAnnika Behrens, Lena Wurmthaler, Felix Heindl, et al.
Breast Care (Basel, Switzerland)|July 12, 2021
Influence of Family History of Breast or Ovarian Cancer on Pathological Complete Response and Long-Term Prognosis in Breast Cancer Patients Treated with Neoadjuvant ChemotherapyMarius Wunderle, Lothar Häberle, Alexander Hein, et al.
Breast (Edinburgh, Scotland)|June 22, 2021
Mammographic density and prognosis in primary breast cancer patientsFelix Heindl, Peter A Fasching, Alexander Hein, et al.
BMC Medical Imaging|July 31, 2020
Breast MRI texture analysis for prediction of BRCA-associated genetic riskGeorgia Vasileiou, Maria J Costa, Christopher Long, et al.
Archives of Gynecology and Obstetrics|June 5, 2024
Correlation of RANK and RANKL with mammographic density in primary breast cancer patientsMarius Wunderle, Felix Heindl, Annika S Behrens, et al.
Gynecologic Oncology|March 15, 2024
Primary results of the AGO-Zervix-1 Study: A prospective, randomized phase III study to compare the effects of paclitaxel and topotecan with those of cisplatin and topotecan in the treatment of patients with recurrent and persistent cervical cancerPaul Gass, Falk C Thiel, Lothar Häberle, et al.
Therapeutic Advances in Medical Oncology|September 30, 2020
Assessment of the additional clinical potential of X-ray dark-field imaging for breast cancer in a preclinical setupJulius Emons, Peter A Fasching, Marius Wunderle, et al.
European Journal of Medical Research|September 28, 2023
Predicting mammographic density with linear ultrasound transducersAnnika Behrens, Peter A Fasching, Eva Schwenke, et al.
Breast Care (Basel, Switzerland)|April 26, 2019
Diagnostic Accuracy of Breast Medical Tactile Examiners (MTEs): A Prospective Pilot StudyMichael P Lux, Julius Emons, Mayada R Bani, et al.
Journal of the American College of Cardiology|July 2, 2013
Phosphodiesterase-2 is up-regulated in human failing hearts and blunts β-adrenergic responses in cardiomyocytesHind Mehel, Julius Emons, Christiane Vettel, et al.
Pageof 8